Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Interferon associated retinopathy.

Hayasaka S, Nagaki Y, Matsumoto M, Sato S.

Br J Ophthalmol. 1998 Mar;82(3):323-5. Review. No abstract available.

2.

Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity.

Oppenheim Y, Ban Y, Tomer Y.

Autoimmun Rev. 2004 Jul;3(5):388-93. Review.

PMID:
15288006
3.

Interferons, serotonin and neurotoxicity.

Menkes DB, MacDonald JA.

Psychol Med. 2000 Mar;30(2):259-68. Review.

PMID:
10824647
4.

Ocular manifestations of hepatitis C virus infection.

Zegans ME, Anninger W, Chapman C, Gordon SR.

Curr Opin Ophthalmol. 2002 Dec;13(6):423-7. Review.

PMID:
12441848
5.

[Interferon and plasma lipids].

García-Escaño MD, Andrade RJ, González-Santos P.

Med Clin (Barc). 2000 Jan 22;114(2):74-6. Review. Spanish. No abstract available.

PMID:
10702954
6.

[Neurologic side effects of interferon therapy].

Kohira I.

Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):610-3. Review. Japanese. No abstract available.

PMID:
10434732
7.

Interferon-induced granulomatous lung disease.

Marzouk K, Saleh S, Kannass M, Sharma OP.

Curr Opin Pulm Med. 2004 Sep;10(5):435-40. Review.

PMID:
15316444
8.

Chronic hepatitis C, depression and interferon.

Horsmans Y.

J Hepatol. 2005 Jun;42(6):788-9. Epub 2005 Apr 1. Review. No abstract available.

PMID:
15885347
9.

[Adverse effect of interferon therapy and its prevention].

Sainokami S, Hino K, Nishiyama Y, Shimoda K.

Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):1026-33. Review. Japanese. No abstract available.

PMID:
7563662
10.

Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.

Berk DR, Mallory SB, Keeffe EB, Ahmed A.

Clin Gastroenterol Hepatol. 2007 Feb;5(2):142-51. Epub 2006 Aug 17. Review. Erratum in: Clin Gastroenterol Hepatol. 2007 Jun;5(6):765.

PMID:
16919505
11.

Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.

Van Thiel DH, Friedlander L, De Maria N, Molloy PJ, Kania RJ, Colantoni A.

Hepatogastroenterology. 1998 Mar-Apr;45(20):328-30. Review.

PMID:
9638401
12.

Neuropsychiatric changes in HIV/hepatitis C coinfected patients undergoing interferon therapy.

Corcoran CP.

J Assoc Nurses AIDS Care. 2003 Sep-Oct;14(5 Suppl):80S-86S. Review.

PMID:
14571562
13.

Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C.

Crone CC, Gabriel GM, Wise TN.

Cleve Clin J Med. 2004 May;71 Suppl 3:S27-32. Review.

PMID:
15468615
14.

[Damage to retinal vasculature].

Sevilla E.

Bull Soc Belge Ophtalmol. 2007;(304):67-70. Review. French.

PMID:
17718229
15.

Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.

Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J.

Clin Infect Dis. 2004 Dec 1;39(11):1724-9. Epub 2004 Nov 8. Review.

PMID:
15578378
16.

[Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C].

Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B.

Gastroenterol Clin Biol. 2005 Feb;29(2):193-6. Review. French.

17.

The role of nursing in managing treatment-associated adverse effects in patients with hepatitis C.

Leone NE.

Gastroenterol Nurs. 2002 Sep-Oct;25(5):201-3. Review.

PMID:
12394396

Supplemental Content

Support Center